A phase I trial of LBS-007 in patients with hematologic cancers
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2018
At a glance
- Drugs LBS 007 (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Haematological malignancies; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; First in man
- 24 Apr 2018 According to a Lin Bioscience media release, this trial is expected to initiate in Q4 of 2018.
- 08 Mar 2017 New trial record
- 03 Mar 2017 According to a Lin Bioscience media release, this trial is expected to initiate in 2017.